Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V H Sethy

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Neuropharmacology|May 1, 1993
Intravenous administration of L-kynurenine to rhesus monkeys: effect on quinolinate and kynurenate levels in serum and cerebrospinal fluidD A Jauch, V H Sethy, B G Weick, et al.
Journal of Medicinal Chemistry|March 18, 1994
Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptorR E TenBrink, W B Im, V H Sethy, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 12, 1976
Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brainV H Sethy, R H Roth, J R Walters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
Milacemide therapy for Parkinson's diseaseM E Giuffra, V H Sethy, T L Davis, et al.
Brain Research|June 15, 1973
Cholinergic neurons: effect of acute septal lesion on acetylcholine and choline content of rat hippocampusV H Sethy, M J Kuhar, R H Roth, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1994
Structure activity relationships of peroxynitrite scavengers an approach to nitric oxide neurotoxicityJ S Althaus, T T Oien, G J Fici, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1994
Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's diseaseL V Metman, V H Sethy, J R Roberts, et al.
Psychopharmacology|June 1, 1997
Anxiolytic-like effects of PNU-101017, a partial agonist at the benzodiazepine receptorA H Tang, S R Franklin, D B Carter, et al.
European Journal of Pharmacology|December 12, 1996
Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtypeM F Piercey, M W Moon, V H Sethy, et al.
Journal of Medicinal Chemistry|January 1, 1982
1-(alkylamino)isochromans: hypotensives with peripheral and central activitiesJ M McCall, R B McCall, R E TenBrink, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Neuropharmacology|May 1, 1993
Intravenous administration of L-kynurenine to rhesus monkeys: effect on quinolinate and kynurenate levels in serum and cerebrospinal fluidD A Jauch, V H Sethy, B G Weick, et al.
Journal of Medicinal Chemistry|March 18, 1994
Antagonist, partial agonist, and full agonist imidazo[1,5-a]quinoxaline amides and carbamates acting through the GABAA/benzodiazepine receptorR E TenBrink, W B Im, V H Sethy, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 12, 1976
Effect of anesthetic doses of gamma-hydroxybutyrate on the acetylcholine content of rat brainV H Sethy, R H Roth, J R Walters, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
Milacemide therapy for Parkinson's diseaseM E Giuffra, V H Sethy, T L Davis, et al.
Brain Research|June 15, 1973
Cholinergic neurons: effect of acute septal lesion on acetylcholine and choline content of rat hippocampusV H Sethy, M J Kuhar, R H Roth, et al.
Research Communications in Chemical Pathology and Pharmacology|March 1, 1994
Structure activity relationships of peroxynitrite scavengers an approach to nitric oxide neurotoxicityJ S Althaus, T T Oien, G J Fici, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 1, 1994
Motor effects of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine (preclamol) in Parkinson's diseaseL V Metman, V H Sethy, J R Roberts, et al.
Psychopharmacology|June 1, 1997
Anxiolytic-like effects of PNU-101017, a partial agonist at the benzodiazepine receptorA H Tang, S R Franklin, D B Carter, et al.
European Journal of Pharmacology|December 12, 1996
Pharmacology of U-91356A, an agonist for the dopamine D2 receptor subtypeM F Piercey, M W Moon, V H Sethy, et al.
Journal of Medicinal Chemistry|January 1, 1982
1-(alkylamino)isochromans: hypotensives with peripheral and central activitiesJ M McCall, R B McCall, R E TenBrink, et al.
Pageof 8